INS and diabetes mellitus: In TRITON-TIMI 38, a benefit of prasugrel over clopidogrel was observed regardless of whether subjects with DM were treated with insulin or not, although the absolute benefit was greater in insulin–treated DM patients (relative risk reduction by 37 % vs 26 %).